Patents by Inventor Patrick J. Scannon

Patrick J. Scannon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CARDIOVASCULAR RELATED USES OF IL-1BETA ANTIBODIES AND BINDING FRAGMENTS THEREOF
    Publication number: 20210009679
    Abstract: Disclosed are methods for the reduction, prevention or treatment of cardiovascular events and/or cardiovascular diseases, including acute cardiovascular disease or chronic cardiovascular disease using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies and fragments thereof). The present disclosure also relates to methods for prevention or treatment of cardiovascular events and/or cardiovascular diseases, including by reducing a cardiovascular event or disease.
    Type: Application
    Filed: February 24, 2020
    Publication date: January 14, 2021
    Applicant: XOMA (US) LLC
    Inventors: Patrick J. Scannon, Alan M. Solinger, Jeffrey D. Feldstein
  • Cardiovascular related uses of IL-1? antibodies and binding fragments thereof
    Patent number: 10611832
    Abstract: Disclosed are methods for the reduction, prevention or treatment of cardiovascular events and/or cardiovascular diseases, including acute cardiovascular disease or chronic cardiovascular disease using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies and fragments thereof). The present disclosure also relates to methods for prevention or treatment of cardiovascular events and/or cardiovascular diseases, including by reducing a cardiovascular event or disease.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: April 7, 2020
    Assignee: XOMA (US) LLC
    Inventors: Patrick J. Scannon, Alan M. Solinger, Jeffrey D. Feldstein
  • Flexible manufacturing system
    Patent number: 10294658
    Abstract: A flexible, multi-product, multi-technology, expandable facility for manufacturing products, such as biologicals, pharmaceuticals, or chemicals, and manufacturing processes using elements of such a facility.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: May 21, 2019
    Assignee: XOMA (US) LLC
    Inventors: Patrick J. Scannon, Frank Bernard, Robert S. Tenerowicz, Alfred C. Dadson, Jr.
  • Flexible manufacturing system
    Patent number: 10106974
    Abstract: A flexible, multi-product, multi-technology, expandable facility for manufacturing products, such as biologicals, pharmaceuticals, or chemicals, and manufacturing processes using elements of such a facility.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: October 23, 2018
    Assignee: XOMA (US) LLC
    Inventors: Patrick J. Scannon, Frank Bernard, Alfred C. Dadson, Jr., Robert S. Tenerowicz
  • CARDIOVASCULAR RELATED USES OF IL-1BETA ANTIBODIES AND BINDING FRAGMENTS THEREOF
    Publication number: 20180155420
    Abstract: Disclosed are methods for the reduction, prevention or treatment of cardiovascular events and/or cardiovascular diseases, including acute cardiovascular disease or chronic cardiovascular disease using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies and fragments thereof). The present disclosure also relates to methods for prevention or treatment of cardiovascular events and/or cardiovascular diseases, including by reducing a cardiovascular event or disease.
    Type: Application
    Filed: July 11, 2017
    Publication date: June 7, 2018
    Inventors: Patrick J. Scannon, Alan M. Solinger, Jeffrey D. Feldstein
  • FLEXIBLE MANUFACTURING SYSTEM
    Publication number: 20170058508
    Abstract: A flexible, multi-product, multi-technology, expandable facility for manufacturing products, such as biologicals, pharmaceuticals, or chemicals, and manufacturing processes using elements of such a facility.
    Type: Application
    Filed: November 11, 2016
    Publication date: March 2, 2017
    Inventors: Patrick J. Scannon, Frank Bernard, Alfred C. Dadson, JR., Robert S. Tenerowicz
  • Methods for the treatment of IL-1? related diseases
    Patent number: 9163082
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: October 20, 2015
    Assignee: XOMA (US) LLC
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES
    Publication number: 20140255391
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: September 30, 2013
    Publication date: September 11, 2014
    Applicant: XOMA Technology Ltd.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer
  • Methods for the treatment of IL-1? related diseases
    Patent number: 8586036
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: November 19, 2013
    Assignee: XOMA Technology Ltd.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer
  • Flexible manufacturing system
    Patent number: 8584349
    Abstract: A flexible, multi-product, multi-technology, expandable facility for manufacturing products, such as biologicals, pharmaceuticals, or chemicals, and manufacturing processes using elements of such a facility.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: November 19, 2013
    Assignee: Xoma Technology Ltd.
    Inventors: Patrick J. Scannon, Frank A. Bernard, Alfred C. Dadson, Jr., Robert S. Tenerowicz
  • Methods for treating IL-1? related diseases by administering an anti-IL-1? antibody
    Patent number: 8545846
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, decreased insulin production, hyperglycemia, hypoinsulinemia, metabolic syndrome, Type 1 diabetes and obesity, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: October 1, 2013
    Assignee: XOMA Technology, Ltd.
    Inventors: Patrick J. Scannon, Alan M. Solinger, Robert J. Bauer
  • Methods for improvement of beta cell function with anti-IL-1? antibodies or fragments thereof
    Patent number: 8377429
    Abstract: Disclosed are methods for improvement of beta cell function in a subject using an anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: February 19, 2013
    Assignee: Xoma Technology Ltd.
    Inventors: Patrick J. Scannon, Alan M. Solinger, Robert J. Bauer
  • Methods for the treatment of IL-1? related diseases
    Patent number: 8101166
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: January 24, 2012
    Assignee: Xoma Technology Ltd.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer
  • METHODS FOR IMPROVEMENT OF BETA CELL FUNCTION
    Publication number: 20120005127
    Abstract: Disclosed are methods for improvement of beta cell function in a subject using an anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: September 4, 2009
    Publication date: January 5, 2012
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Patrick J. Scannon, Alan M. Solinger, Robert J. Bauer
  • METHODS FOR TREATING OR PREVENTING IL-1BETA RELATED DISEASES
    Publication number: 20120003226
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, decreased insulin production, hyperglycemia, hypoinsulinemia, metabolic syndrome, Type 1 diabetes and obesity, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: September 4, 2009
    Publication date: January 5, 2012
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Patrick J. Scannon, Alan M. Solinger, Robert J. Bauer
  • FLEXIBLE MANUFACTURING SYSTEM
    Publication number: 20110258837
    Abstract: A flexible, multi-product, multi-technology, expandable facility for manufacturing products, such as biologicals, pharmaceuticals, or chemicals, and manufacturing processes using elements of such a facility.
    Type: Application
    Filed: December 22, 2009
    Publication date: October 27, 2011
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Patrick J. Scannon, Frank Bernard, Robert S. Tenerowics, Alfred C. Dadson, JR.
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES
    Publication number: 20110038859
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: April 9, 2010
    Publication date: February 17, 2011
    Applicant: XOMA Technology Ltd.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer, David Alleva
  • CARDIOVASCULAR RELATED USES OF IL-1BETA ANTIBODIES AND BINDING FRAGMENTS THEREOF
    Publication number: 20100316651
    Abstract: Disclosed are methods for the reduction, prevention or treatment of cardiovascular events and/or cardiovascular diseases, including acute cardiovascular disease or chronic cardiovascular disease using anti-IL-1? binding molecules (e.g., IL-1? binding antibodies and fragments thereof). The present disclosure also relates to methods for prevention or treatment of cardiovascular events and/or cardiovascular diseases, including by reducing a cardiovascular event or disease.
    Type: Application
    Filed: May 28, 2010
    Publication date: December 16, 2010
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: PATRICK J. SCANNON, ALAN M. SOLINGER, JEFFREY D. FELDSTEIN
  • METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES
    Publication number: 20100303807
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Application
    Filed: February 23, 2010
    Publication date: December 2, 2010
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer, David Alleva
  • Methods for the treatment of IL-1? related diseases
    Patent number: 7695718
    Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1? antibody or fragment thereof.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: April 13, 2010
    Assignee: Xoma Technology Ltd.
    Inventors: Alan M. Solinger, Patrick J. Scannon, Robert J. Bauer